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 Abstract 
 
During heat stress the human body thermoregulates via cutaneous vasodilation and 
sweating. Hypohydration can impair thermoregulatory responses that stem from the central 
nervous system (CNS), but it is unknown if impairments also occur post-synaptically in the 
microcirculation. Moreover, obese individuals may have impaired thermoregulation, possibly 
due to microvascular dysfunction. Purpose: The purpose of these studies was two-fold: 1) to 
determine if obese (OB) individuals exhibit impairments in thermoregulatory responses during 
exercise heat-stress (centrally-mediated) and intradermal infusion of vasoactive substances 
(peripherally-mediated) versus non-obese (N-OB), and 2) to determine if hypohydration 
subsequently affects these thermoregulatory responses differently between groups. Methods: 
Twenty-one healthy, college-age males were classified as either N-OB (n = 11, body fat [BF] 
<20%) or OB (n = 10, BF >26%) and completed a comprehensive 2-day protocol. In a 
randomized, counter-balanced order, subjects performed 60 min of cycling in a hot environment 
while either euhydrated (EU) or hypohydrated (HY) (Study 1). Changes in rectal temperature 
(∆Trec), cutaneous vascular conductance (CVC), and local sweat rate (LSR) were recorded. 
Following exercise, subjects maintained a EU or HY condition and returned 24-h later to 
undergo cutaneous microdialysis (MDS) of the forearm (Study 2). Dose-response curves 
comparing CVC and LSR responses were compared while sub-cutaneously perfusing the 
endothelium-dependent vasodilator methacholine chloride (MCh) and the endothelium-
independent vasodilator sodium nitroprusside (SNP). Results: In Study 1, compared to EU, HY 
increased end-exercise ∆Trec in N-OB (0.47 ± 0.37°C, p < 0.01) but did not in OB (-0.06 ± 
0.29°C, p > 0.05). LSR and CVC were not different between groups or hydration condition (p > 
0.05). In study 2, OB subjects had a higher Log EC50 versus N-OB for endothelium-independent 
 CVC (-1.69 ± 0.17 vs. -2.13 ± 0.06 Log [SNP] M, p = 0.014) when EU. There were no 
differences between groups in endothelium-dependent CVC or LSR responses in either hydration 
condition (all p > 0.05). Conclusions: These data suggest that hydration status affects the core 
body temperature response differently in N-OB and OB males during exercise heat-stress. In 
addition, OB individuals appear to have impaired post-synaptic endothelium-independent CVC, 
but similar endothelium-dependent CVC and LSR versus N-OB. 
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CHAPTER ONE 
 
Introduction 
 The ability to dissipate heat and maintain appropriate thermal homeostasis is vital for 
humans, both at rest and during conditions of physiological stress (i.e., exercise and/or heat 
stress). Heat dissipation occurs primarily through increases in sweating (evaporative heat loss) 
and skin blood flow (convective heat loss). Impairments in these thermoregulatory responses can 
lead to drastic increases in core body temperature when individuals are exposed to high 
environmental temperatures and/or during exercise. Changes in thermoregulatory function are 
mediated through two primary avenues: 1) the central nervous system (CNS, “centrally 
mediated”) and 2) at the level of the skin (“peripherally mediated”). The hypothalamus is 
responsible for maintaining thermal homeostasis, and as such, will respond to increases in body 
temperature, bringing about a cascade of events that lead to increases in sweating and a 
redistribution of blood flow from the core to the skin in an effort to dissipate heat. In addition, 
changes in sweating and skin blood flow can also be modified by changes in skin temperature 
(15) and/or infusion of certain drugs (8, 11), independent of changes in core body temperature or 
neural signaling. Thus, impairments in thermoregulation may be present in more than one 
location of the body. For example, the CNS could misinterpret changes in skin/core temperature 
and not send the appropriate response signal to the skin. Alternatively, temperature changes may 
be interpreted and an appropriate CNS response initiated, but impairments at the level of the skin 
(i.e., blood vessels and/or sweat glands) result in an impaired response (i.e., post-synaptic 
impairment).  
 
2 
 
 Obesity is often suggested to be a contributing factor to increased core temperature (i.e., 
hyperthermia) and epidemiological data support the hypothesis that obese individuals are at 
increased risk for developing heat illness (4, 6). Early research suggested that during exercise, 
obese individuals have lower heat tolerance, lower sweat production, and less heat activated 
sweat glands versus non-obese individuals (2, 3). Further, the largest influence on body 
temperature during exercise has been suggested to be body fat and the surface area to mass ratio 
(12). Vroman et al. demonstrated that obese individuals have lower forearm blood flow (an index 
of skin blood flow) when exercising in a hot environment compared to their non-obese 
counterparts (18). This decreased skin blood flow was thought to be attributed to increased 
sympathetic vasoconstrictor activity to the obese skin circulation. In contrast, more recent 
investigations, accounting for differences in relative exercise intensity through controlling 
metabolic heat production, have shown no differences in thermoregulatory responses between 
obese and non-obese males (13) and females (1) during low intensity aerobic exercise. 
Conflicting observations in the current literature may be due to differences in study design (i.e., 
relative versus absolute exercise workloads) or the amount of physiological stress imposed 
during the investigation. The type of workload is important when comparing populations with 
differing levels of body fatness (7, 10). The use of a relative metabolic heat production workload 
(e.g., Watts per kg body mass) allows for fair comparisons between groups since it accounts for 
individual differences in body mass and subsequent power generation (i.e., wattage) while 
cycling. Further, exercise protocols that induce a greater amount of physiological stress (i.e., 
higher intensity physical activity) are more likely to elicit differences in thermoregulatory 
function between various populations, as observed recently with older individuals (17).  
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It is also possible that hydration status influences thermoregulatory responses differently 
in obese versus non-obese individuals. Dehydration has been shown to have a significant effect 
on thermoregulatory function in non-obese individuals during exercise. Dehydration prior to and 
during exercise leads to increased core body temperature secondary to reductions in skin blood 
flow and sweating, and these effects are directly related to the magnitude of dehydration (14, 16). 
During exercise, the thermoregulatory system is somewhat at odds with the renin-angiotensin-
aldosterone-system (RAAS) in that increases in fluid losses (i.e., sweating) must occur to 
preserve thermal homeostasis, but RAAS is functioning to maintain body water homeostasis (i.e., 
fluid conservation). In obese individuals, increased basal plasma renin activity and angiotensin II 
levels are associated with increased sympathetic nerve activity (SNA) and subsequent increased 
vasoconstriction (5). Given the complexity of maintaining body fluid balance, particularly under 
conditions of physiological stress, it is possible that dehydration affects the relationship between 
RAAS and thermoregulatory function to a greater degree in obese versus non-obese individuals 
during exercise. Therefore, impairments in thermoregulatory function in obese individuals that 
may be present when euhydrated could be further exacerbated when dehydrated versus non-
obese counterparts. 
 During exercise heat stress, local sweat rate and skin blood flow increase as body 
temperature increases. Increases in these parameters are a result of changes in core and skin 
temperature, and as such, are driven from a combination of central and peripheral inputs to the 
hypothalamus. More recently, the use of cutaneous microdialysis has been used to isolate post-
synaptic thermoregulatory function in a number of different populations (8, 9, 11). That is, 
outcomes from microdialysis provide insight into whether or not there is an impaired 
thermoregulatory responses at the level of the skin (i.e., blood vessels and/or sweat glands). The 
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technique allows for assessment of cutaneous active vasodilation and sweating by sub-
cutaneously infusing known vasodilator and neurotransmitter substances that induce localized 
increases in skin blood flow and sweating. Since this drug infusion occurs at the level of the skin, 
localized changes in thermoregulatory function are not driven by the CNS (i.e., they are 
mediated peripherally, post-synaptically, at the level of the skin).  
 In order to test the hypothesis that differences in thermoregulatory function between 
obese and non-obese individuals are modified by hydration status, subjects completed a 
comprehensive protocol while either euhydrated or hypohydrated. This study involved an 
exercise protocol to assess whole-body thermoregulatory responses and a skin microdialysis 
procedure to assess cutaneous thermoregulatory responses. The two-day protocol was performed 
twice; once while euhydrated and once while hypohydrated. This allowed for a thorough 
investigation of possible differences between obese and non-obese individuals in centrally 
mediated (whole-body heat stress) versus peripherally mediated (microdialysis) 
thermoregulatory function and how the magnitude of these differences were modified affected by 
hydration status.  
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Abstract 
 Obesity may be associated with impaired cutaneous vasodilation and sweating responses 
to exercise heat stress. Hypohydration (HY) impairs thermoregulatory responses in non-obese 
(N-OB) individuals, but it is unknown if HY affects these responses differently in obese (OB) 
versus N-OB individuals compared to a euhydrated (EU) condition. Purpose: To test the 
hypothesis that OB males have impaired thermoregulatory responses to exercise heat-stress 
versus N-OB, and HY further exacerbates these responses. Methods: N-OB (n = 11, BM 73.9 ± 
8.5 kg, BF% 13.6 ± 3.8) and OB (n = 9, BM 89.6 ± 6.9 kg, BF% 30.2 ± 4.1) males, in a 
randomized cross-over design, performed 60 min of upright cycling in a hot environment (40.3 ± 
0.4°C, relative humidity 32.5 ± 1.9%) at a metabolic heat production of 6 W/kg BM while either 
euhydrated (EU) or HY. Change in rectal temperature (∆Trec), local sweat rate (∆LSR), and 
cutaneous vascular conductance [expressed as percent of maximum, %CVCmax]) from pre-
exercise baseline were collected throughout. Results: When EU, both N-OB had similar CVC 
and LSR responses (p > 0.05); however, N-OB had a lower ∆Trec versus OB (0.92 ± 0.35 vs. 1.31 
± 0.32°C, p = 0.021). Compared to EU, HY increased end-exercise ∆Trec in N-OB (0.47 ± 
0.37°C, p < 0.01) but did not in OB (-0.06 ± 0.29°C, p > 0.05). ∆LSR and ∆CVC were not 
different between groups or hydration condition (p > 0.05). Conclusions: These data suggest that 
hypohydration affects cutaneous vasodilatory and sweating responses to exercise heat-stress in a 
similar manner in N-OB and OB males. However, hypohydration increases rectal temperature 
versus a euhydrated condition in N-OB but not OB males.  
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Introduction 
 The ability to effectively dissipate heat during exercise is critical to preventing excessive 
increases in core body temperature and subsequent heat illness (23). Obesity continues to be a 
significant global health concern (33) and data suggest that this population may be at an 
increased risk of developing heat illness (7, 14). Previous studies suggest that obese individuals 
may have impaired thermoregulatory responses versus non-obese counterparts during sustained 
aerobic exercise. During exercise heat stress, obese individuals have been shown to have lower 
heat tolerance, sweat production, and less heat activated sweat glands versus non-obese 
individuals (5, 6). Similarly, decreased forearm blood flow (an index of skin blood flow) has 
been observed in obese males exercising in a hot environment (51).  
 Despite these initial findings regarding thermoregulation in obese individuals, recent 
work examining how best to compare individuals of different body size suggests earlier work in 
this area may be systematically flawed (16, 18). Thus, the question of whether obese individuals 
truly have impairments in thermoregulatory responses, particularly during exercise, remains 
unclear. Assigning metabolic heat production relative to body mass has been accepted as the 
correct method to compare thermoregulatory responses between groups (16). Dervis et al. 
observed a higher core body temperature during an aerobic exercise bout in high- versus low-
body fat groups matched for body mass when cycling at a workload of ~6 W/kg body mass (18). 
This was despite no differences in local or whole body sweating responses. However, exercise 
was performed in a compensable environment (28°C, 26% relative humidity); thus, it is unclear 
how these responses may differ in a physiologically uncompensable environment. Further 
evidence suggests that individuals of large body mass can have significantly higher local and 
whole body sweat rates versus those with lower body mass during exercise, independent of 
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differences in metabolic heat production normalized to body surface area (17). This suggests that 
individuals with greater body mass may have an impaired capacity for heat dissipation during 
exercise heat stress versus individuals of lower body mass (i.e., obese versus non-obese). 
Acute and chronic dehydration (herein referred to as hypohydration) have been shown to 
have a significant influence on core temperature, sweating, and skin blood flow responses during 
exercise in non-obese individuals (34-36, 46). Moreover, the degree of hypohydration is directly 
related to the magnitude of reduction in these responses (35, 46). However, it is unknown if the 
increased thermal strain accompanying hypohydration in non-obese affects obese individuals to 
the same extent during exercise. In addition, in much of the previous work investigating 
thermoregulatory differences between groups with large differences in body mass and/or body 
fat, hydration status was either not controlled during exercise or was not reported (5, 6, 16, 18, 
51). Since obesity is associated with increased basal plasma renin activity and angiotensin II 
levels, which is associated with increased sympathetic nerve activity (SNA) (3, 11, 30, 42), 
obese individuals may exhibit an impaired vasodilatory response during exercise, and thus, 
reduced convective heat loss versus non-obese.  Further, under conditions of increased 
physiological stress (i.e., hypohydration), any potential reductions in convective heat loss that are 
present when euhydrated may be further exacerbated. Given the complexity of maintaining body 
fluid balance, particularly under conditions of physiological stress, it is possible that 
hypohydration affects the relationship between body fluid balance mechanisms (i.e., the renin-
angiotensin-aldosterone-system) and thermoregulatory function to a greater degree in obese 
versus non-obese individuals during exercise. Therefore, impairments in thermoregulatory 
function in obese individuals that may be present when euhydrated could be further exacerbated 
when dehydrated versus non-obese counterparts. 
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 Therefore, the aim of the present study was two-fold: 1) to determine if impairments in 
thermoregulatory responses are present in obese (OB) versus non-obese (N-OB) males during an 
exercise heat stress bout in a physiologically uncompensable environment  while euhydrated, and 
2) to determine if hypohydration subsequently affects thermoregulatory responses differently in 
OB versus N-OB males during exercise heat stress. We hypothesized that OB subjects would 
have impairments in thermoregulatory responses while euhydrated, and this impairment would 
be further exacerbated while hypohydrated versus their N-OB counterparts.   
Materials and Methods 
Subjects 
 Twenty healthy adult males from the University and surrounding community volunteered 
to participate in the study. In order to be considered eligible, subjects were required to have a 
stable body weight (i.e., not actively trying to lose or gain weight), be willing to abstain from 
caffeine and alcohol on lead-in and testing days, be free of any medications or supplements that 
may affect body weight or fluid balance, be free of any metabolic and/or cardiovascular 
disorders, and abstain from physical activity beyond normal activities of daily living during a 48-
h experimental period. All subjects were required to provide written informed consent prior to 
participation through signing a document that was approved by the University’s Institutional 
Review Board.  
An a priori power calculation was performed using SigmaPlot v. 12 (Systat Software 
Inc., San Jose, CA) with an α of 0.05, a β of 0.20, and an estimated smallest significant 
difference (0.35°C) in the primary outcome variable (rectal temperature change; ∆Trec) from 
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previous studies using similar protocols (16, 18, 25), adequate power could be achieved with a 
sample of nine subjects per group. 
During a screening visit, body fat (BF) percentage, fat-free mass (FFM), and lean body 
mass (LBM) were determined via dual-energy X-ray absorptiometry (DXA; Lunar Prodigy, 
General Electric®, Madison, WI). Subjects with a BF <18% were classified as non-obese (N-
OB; n = 11) and those ≥26% obese (OB; n = 9) (27). Subject demographic data are presented in 
Table 1. Subjects had their height measured using a standard stadiometer (Seca 216 stadiometer, 
Chino, CA) and nude body mass (BM) using a platform scale (Health-O-Meter, Model 349KLX, 
Alsip, IL). These values were used to calculate body surface area (BSA) according to Dubois and 
Dubois (20) and body mass index (BMI). Mean specific heat of the body (Cp) was estimated 
using a previously described formula (28). A digital bathroom scale was provided to subjects 
(High Accuracy Bathroom Scale, BalanceFrom LLC, China) to measure morning euhydrated 
BM during a 3-day baseline period to use for calculations of BM change with various hydration 
states (13). Subjects completed the International Physical Activity Questionnaire (9) to assess 
habitual physical activity levels. Peak oxygen uptake (VO2peak) was measured via indirect 
calorimetry (TrueOne® 2400, Parvo Medics, Sandy, UT) with subjects completing an 
incremental graded exercise test on a mechanically-braked cycle ergometer (Veletron, 
RacerMate Inc., Seattle, WA). Starting at a resistance of 50 W, resistance increased 25 W every 
two minutes until either volitional fatigue or a reduction in cadence below 30 rpm occurred. 
Values of absolute VO2 (L/min) and respiratory exchange ratio (RER) from this test were used to 
calculate appropriate starting external resistance during the subsequent experimental trials.  
Experimental Procedures 
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 To assess differences in thermoregulatory function during exercise in the heat between N-
OB and OB males, in a randomized, counter-balanced order, subjects completed 60 min of 
cycling in a hot environment (ambient temperature 40.3 ± 0.4°C, relative humidity 32.5 ± 1.9%) 
while either euhydrated (EU) or hypohydrated (HY). For both trials, 24-h prior to subjects’ 
arrival at the laboratory for testing, they were required to abstain from physical activity outside 
of activities of daily living and were restricted to drinking water only. During this same period, 
subjects recorded all food intake that could then be replicated for the second trial. For EU trials, 
euhydration was achieved through prescribing 24-h water intake of 45 ml·kg-1 and 
hypohydration was achieved in the HY trials via 24-h fluid restriction of 237 ml (~8 oz).  
 Following instrumentation and collection of baseline urine and blood measures, subjects 
entered an environmental chamber wearing athletic shorts and shoes and rested on the cycle 
saddle for ~20 min to allow body fluid compartments to stabilize. Baseline perceptual and 
physiological measures were made before a blood sample was taken. Subjects then began 
exercise starting at a pre-determined external wattage with a target relative metabolic heat 
production (MHP; W·kg-1) of 6 W·kg-1. Absolute VO2 (L/min) and RER were assessed every 5-
10 min during exercise and external wattage was adjusted accordingly to ensure the target MHP 
was maintained. Metabolic heat production was calculated by subtracting external work 
performed (Watts) from metabolic energy expenditure. Metabolic energy expenditure (M) was 
calculated from VO2 and RER during exercise using the formula M = VO2[(((RER – 0.7)/0.3) x 
ec) + (((1 – RER)/0.3) x ef)], where ec is the caloric equivalent per liter of oxygen for the 
oxidation of carbohydrates (21.13 kJ), and ef is the caloric equivalent per liter of oxygen of fat 
(19.62 kJ) (39). Heat storage (S; W·m-2) was calculated as S = 
(0.965·BM)((0.9·∆Trec)+(0.1·∆Tsk))/BSA, where BM is pre-exercise body mass (kg), ∆Trec is the 
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change in rectal temperature (Trec; °C), ∆Tsk is the change in mean skin temperature (Tsk; °C), 
and BSA is body surface area (m2) (2).  
 At 15, 30, 45, and 60 min, perceptual data, blood pressure, and sweat gland activation 
(SGA) were collected. Heart rate, Trec, Tsk, SkBF, and LSR were recorded continuously 
throughout the protocol using data acquisition software (LabChart 7, ADInstruments, Colorado 
Springs, CO) at a frequency of 50 Hz. Reported values for these variables were taken during 
~20-30 s periods at the specific time points (i.e., 15 min intervals) during blood pressure 
measurement. During the EU trials, subjects were provided warm drinking water (~38°C) at 15, 
30, and 45 min in ~5 ml·kg-1 boluses to maintain euhydration. This fluid intake volume was 
chosen following pilot testing and was adequate to ensure euhydration (assessed via %BM 
change) for all subjects. Fan created airflow was not used during exercise; however, subjects’ 
skin was regularly wiped down with a towel to facilitate evaporative heat loss. Immediately 
following exercise, a body mass was taken after subjects were toweled dry and had removed 
shoes and a urine sample was collected. 
Experimental Measures 
 Blood pressure (Tango+, SunTech Medical, Morrisville, NC) was measured at the right 
brachial artery via electrosphygmomanometry, and HR was measured using a standard Polar® 
heart rate monitor (Polar Electro, Lake Success, NY). Mean arterial pressure (MAP) was 
calculated as MAP = (1/3·systolic blood pressure) + (2/3·diastolic blood pressure). 
 Rectal temperature (Trec) was measured using a rectal thermistor (Physitemp Instruments 
Inc., Clifton, NJ) inserted at least 15 cm beyond the anal sphincter. Skin temperature (Tsk) was 
measured using four Type T thermocouples (Omega Engineering, Stamford, CT) placed on the 
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left anterior thigh (midway between the greater trochanter and lateral condyle), chest (midway 
between the axilla and areola), lateral calf (midway between the tibial condyle and malleolus), 
and upper arm. Mean-weighted Tsk was calculated using the formula Tsk = 0.3(chest) + 0.3(upper 
arm) + 0.2(thigh) + 0.2(calf) (41). Rectal and mean skin temperatures were used to calculate 
mean body temperature (Tb) using the formula Tb = 0.1(Tsk) + 0.9(Trec) (49). 
Red blood cell flux, an index of skin blood flow (SkBF), was assessed by laser-Doppler 
flowmetry (38) on the left dorsal forearm with a probe (laser-Doppler perfusion monitor and 
Probe 2b, Moor Instruments, Wilmington, DE) held in place by a local heater (Perflux System 
5000, Perimed, Ardmore, PA) and attached to the skin surface with adhesive tape. Changes in 
cutaneous vasomotor activity, expressed as cutaneous vascular conductance (CVC), were 
calculated by dividing red blood cell flux by MAP and reported as a percentage of maximal CVC 
(%CVCmax). Maximal CVC was determined at the end of the trial by locally heating the skin at 
44°C for 30 minutes or until a plateau occurred (12). 
Adjacent to the laser-Doppler probe, local sweat rate (LSR) was measured using a 2.85 
cm2 ventilated capsule held on the skin by adhesive tape. Dry nitrogen gas was supplied through 
the capsule at a rate of 0.3 l·min-1. The absolute humidity (g/m3) and ambient temperature from 
the effluent air of the capsule were monitored by a humidity and temperature sensor (HMT333, 
Vaisala, Woburn, MA) and LSR (mg·cm-2·min-1) was calculated as LSR = ([flow rate in 
mg3/min·absolute humidity in gm/3] / [capsule surface area in cm2])·1000.  Whole body sweat 
rate (WBSR; L/h) and percent BM loss were calculated using nude BM measures pre- and 
immediately post-exercise, accounting for any fluid ingested during the protocol, respiratory 
water loss, blood loss from sampling during exercise, and urine formation. 
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SGA was measured by wiping the skin dry and lightly applying a 2.85 cm2 circular piece 
of iodine impregnated paper to a site immediately adjacent to the local sweat rate capsule for ~5 
s (26). Two consecutive samples were collected at 15, 30, 45, and 60 min during exercise. All 
images were immediately scanned and analyzed as previously described (26). Relative SGA 
(glands/cm2) was determined by dividing the number of active sweat glands by 2.85 cm2. 
Sweat output per gland (SGO; μg·gland-1·min-1) was calculated by dividing LSR at the 
time of measurement by the corresponding number of activated sweat glands. Methodologically, 
it is not possible to collect SGA samples underneath the sweat capsule during measurement of 
LSR (ambient humidity would render the LSR inaccurate). However, to confirm that the same 
number of sweat glands were activated underneath the sweat capsule as the adjacent site (where 
SGA was measured throughout exercise), SGA was collected under the sweat capsule during the 
last minute of exercise (~60 min). Differences between the LSR and adjacent sites were 35 ± 43 
and 4 ± 45 in the EU trials and 31 ± 43 and 4 ± 22 glands/cm2 in the HY trials in N-OB and OB 
groups, respectively. Due to technical difficulties, several subjects were unable to be included in 
the final analysis. Data for SGA and SGO are reported as N-OB (n = 8) and OB (n = 6). 
Throughout the exercise protocol, subjects were asked to provide ratings of perceived 
exertion (RPE; range 6-20), thermal sensation (TS; 0.5-10), muscle pain (MP; 0.0-10), thirst 
(TH; 0-9), comfort (COM; 1-5), and motivation to continue (MOT; 1-5) (10, 15, 22, 50). Results 
of these measures are provided in Appendix A. 
Urine and Blood Analysis 
 Upon arriving at the laboratory, subjects provided a urine sample which was analyzed for 
USG using a hand-held refractometer (Master-SUR/NM, ATAGO, Japan), osmolality (Uosm), and 
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color. Urine osmolality was measured in duplicate using freezing point depression osmometry 
(Model 3250, Advanced Instruments Inc., Norwood, MA). Color was assessed in a well-lit room 
using the eight-level color scale where the sample was in a glass tube against a plain white 
background (4, 31). The same measures were performed on a post-exercise urine sample and 
samples were weighed to the nearest 5 g (i.e., 5 ml) (OHAUS Catapult 1000, Pine Brook, NJ) to 
determine volume.  
 Baseline blood samples (collected outside the environmental chamber) were collected via 
an intravenous catheter (SurFlash®, Terumo Corporation, Tokyo, Japan) placed in a superficial 
forearm vein while subjects were in a reclined position in a phlebotomy chair for at least 20 min. 
Whole blood was drawn into a 6 ml Vacutainer collection tube with EDTA additive for analysis 
of hemoglobin (Hb), hematocrit (Hct), and carboxyhemoglobin concentration (HbCO%). A 4 ml 
clot activator tube was used for analysis of serum osmolality (Sosm). Osmolality was measured in 
duplicate fresh samples using freezing point depression osmometry (Model 3250, Advanced 
Instruments Inc., Norwood, MA). Hemoglobin was measured in triplicate 10 µl samples using a 
HemoCueHb 201+ analyzer (HemoCue AB, Angelholm, Sweden). Hematocrit was analyzed in 
triplicate 35 µl samples drawn into microcapillary tubes, spun down in a microcentrifuge for 
three minutes at 12,000 rpm (UNICO model C-MH30, Dayton, NJ), and values measured on a 
Damon Micro-Capillary Reader (Needham Heights, MA).  
Determination of Red Cell Volume, Plasma Volume, Blood Volume, and Plasma Volume 
Change 
 Red cell volume (RCV), plasma volume (PV), and blood volume (BV) were determined 
using the optimized CO-rebreathing method described by Schmidt and Prommer (47). A baseline 
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blood sample was drawn and analyzed for HbCO% using an ABL80 FLEX OSM-3 co-oximeter 
(Radiometer, Denmark). Additional blood samples were drawn and analyzed at 6 and 8 minutes 
after beginning the rebreathing procedure, with an average of these measures (i.e., 7 minutes) 
being used for the calculation of ∆HbCO%. A portable CO analyzer with parts-per-million 
sensitivity (Pac 7000, Dräger Safety AG & Co. KGaA, Lübeck, Germany) was used to monitor 
potential gas leaks during the rebreathing procedure and to determine CO concentration 
remaining in the lungs and breathing bag following completion of the procedure. RCV, PV, and 
BV were then calculated using baseline values of [Hb] and Hct (described previously) using the 
following formulas (29): 
RCV = BV * Hct 
PV = BV – RCV 
BV = RCV / [Hb] 
Relative PV and BV (PVrel and BVrel, respectively) were calculated by dividing PV and 
BV by pre-exercise BM. Due to technical difficulties, results are presented as N-OB (n = 9) and 
OB (n = 6) for RCV, PV, BV, PVrel and BVrel.  
Statistical procedures 
Statistical analyses were performed using SPSS v. 23 for Windows (IBM Corporation, 
Somers,, NY). Two-way repeated measures ANOVA were used to compare changes in HR, 
MAP, Trec, Tsk, %CVCmax, and LSR during exercise when each subject group was EU. To test 
how hypohydration differentially affected these measures between groups, a difference valuable 
was calculated by subtracting EU from HY values at each time point. Results of analyses 
comparing groups only when HY are provided in Appendix B. Differences in hydration 
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measures, WBSR, external workload, MHP, heat storage, and exercise intensity were compared 
within and between groups using dependent and independent t-tests, respectively. 
While all N-OB subjects completed the full exercise protocol in both hydration 
conditions, three OB subjects were unable to finish the full 60 min when euhydrated (exercise 
times of 50, 53, and 53 min, respectively), and two OB subjects were unable to finish while 
hypohydrated (40 and 53 min). A two-way repeated measures ANOVA was used to compare 
changes values of HR, Trec, Tsk, %CVCmax, and LSR from pre-exercise baseline using all subjects 
up to 45 min of exercise. The 60 min time-point represents the end-exercise value for all subjects 
and was compared using independent t-tests. Raw values of HR and MAP were also compared in 
the same manner. 
Data are reported as mean ± standard deviation (SD). An alpha level of 0.05 defined 
significance for all tests. Greenhouse-Geisser corrections and follow up tests were performed as 
necessary. 
Results 
External Workload, Metabolic Heat Production (MHP), Heat Storage, and Exercise Intensity 
 Values of average external workload, MHP (expressed in absolute and relative [per kg 
body mass] Watts), heat storage (W·m2), and exercise intensity (expressed as %VO2peak) for both 
groups in each trial are presented in Table 2. As expected, OB subjects required a higher external 
workload versus N-OB subjects to achieve the same MHP in watts per kg body mass in both the 
EU (p = 0.016) and HY (p = 0.020) trials. Consequently, relative exercise intensity was also 
higher for OB vs. N-OB subjects in the EU (p = 0.002) and HY (p < 0.001) trials. Likewise, 
absolute MHP was higher in OB versus N-OB subjects for both the EU (p = 0.001) and HY trials 
(p < 0.001). Importantly, external workload, and relative exercise intensity were not different 
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between the EU and HY trials within groups (all p > 0.05). Similarly, MHP (W·kg-1) was not 
different within or between groups in either hydration condition (p > 0.05). Heat storage was not 
different between EU or HY trials in OB subjects (p = 0.807), but was significantly lower in N-
OB when EU versus HY (p = 0.006). While groups had similar levels of heat storage when HY 
(p = 0.525), it was significantly lower in N-OB versus OB when EU (p = 0.022).  
Hydration Status Measures 
 Pre- and post-exercise measures of ∆BM, USG, Uosm, Ucol, and Sosm are presented in Table 
3. As intended, there was a main effect of hydration condition, with greater pre-exercise ∆BM, 
USG, Uosm, Ucol, and Sosm in the HY versus EU trials, independent of group (all p < 0.001).  
 Independent of group, pre-exercise, 15, and 60 min Sosm was higher in the HY versus EU 
trials (all p < 0.001). During EU trials no differences in Sosm were present between N-OB versus 
OB subjects at pre-exercise (288 ± 4 vs. 288 ± 4), 15 (294 ± 5 vs. 293 ± 4), or 60 min (288 ± 5 
vs. 288 ± 4 mOsm·kg-1) (all p > 0.05). Similarly, in the HY trials no differences were present at 
pre-exercise (292 ± 4 vs. 293 ± 4), 15 (298 ± 3 vs. 299 ± 5), or 60 min (300 ± 4 vs. 299 ± 5 
mOsm·kg-1) (all p > 0.05). 
 There were no baseline differences in RCV, absolute PV, or absolute BV between N-OB 
and OB subjects in either the EU or HY trials (Table 4; all p > 0.05). Independent of hydration 
condition, N-OB subjects had significantly higher PVrel and BVrel versus OB subjects (both p < 
0.001).  
Rectal (Trec), Mean Skin Temperature (Tsk), and Mean Body Temperature (Tb) Responses 
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 In the EU trials, ∆Trec increased over time in both groups (p < 0.001), but there was no 
interaction between time and group (p = 0.150; Figure 1A). N-OB subjects had a lower ∆Trec 
versus OB subjects at 45 (0.82 ± 0.31 vs. 1.15 ± 0.26°C) and 60 (0.92 ± 0.35 vs. 1.33 ± 0.34°C) 
min (both p < 0.05).  
The effect of hypohydration on ∆Trec during exercise for both groups is presented in 
Figure 2A. There was a significant interaction between group and time (p = 0.016). When 
hypohydrated, ∆Trec was elevated in N-OB versus OB subjects at 45 and 60 min (0.39 ± 0.39 vs. 
-0.07 ± 0.33 and 0.47 ± 0.37 vs. -0.06 ± 0.29°C, respectively, both p < 0.05) versus the EU 
condition.  
 In the EU trials, ∆Tsk decreased over time in both groups (p < 0.001), but there was no 
interaction between time and group (p = 0.645; Figure 1B). There were no differences between 
groups at any time point (all p > 0.05).  
The effect of hypohydration on ∆Tsk during exercise for both groups is presented in 
Figure 2B. During exercise, the interaction between group and time was not significant (p = 
0.197). However, at 60 min, ∆Tsk was further decreased when HY in N-OB (-0.77 ± 1.18°C), but 
elevated in OB (1.05 ± 0.72°C) compared to the EU condition (p < 0.001).  
 In the EU trials, ∆Tb increased over time in both groups (p < 0.001), but there was no 
interaction between time and group (p = 0.221; Figure 1C). N-OB subjects tended to have a 
lower ∆Tb verus OB subjects at 15 (0.20 ± 0.13 vs. 0.37 ± 0.22°C, p = 0.066) and 60 (0.68 ± 0.35 
vs. 1.02 ± 0.34°C, p = 0.054) min. ∆Tb was lower in N-OB versus OB subjects at 30 and 45 min 
(0.43 ± 0.20 vs. 0.63 ± 0.19 and 0.57 ± 0.31 vs. 0.89 ± 0.29°C, respectively, p < 0.05).  
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The effect of hypohydration on ∆Tb during exercise for both groups is presented in Figure 
2C. During exercise, there was a trend towards a significant interaction between group and time 
(p = 0.080). When hypohydrated, ∆Tb was elevated in N-OB versus OB subjects at 45 and 60 
min (0.33 ± 0.30 vs. -0.02 ± 0.33 and 0.38 ± 0.34 vs. 0.05 ± 0.28°C, respectively, both p < 0.05) 
versus the EU condition.  
Cutaneous Vascular Conductance (CVC) 
 For ∆CVC (expressed as a percent of maximum CVC [%CVCmax]) in the EU trials, there 
was a trend towards a main effect of time (p = 0.076), but the interaction between group and time 
was not significant (p = 0.887; Figure 3A). There were no differences between groups at any 
time point (all p > 0.05).   
The effect of hypohydration on ∆CVC for both groups is presented in Figure 4A. The 
interaction between group and time was not significant (p = 0.862) and there were no differences 
between groups in ∆CVC at any time point when HY versus EU (all p > 0.05). 
Local Sweat Rate (LSR), Whole Body Sweat Rate (WBSR), Sweat Gland Activation (SGA) and 
Sweat Gland Output (SGO) 
 In the EU trials, there was a main effect of time for LSR (p < 0.001), but the interaction 
between group and time was not significant (p = 0.395; Figure 3B). There were no differences 
between groups at 15, 30, or 45 min (all p > 0.05); however, N-OB subjects tended to have a 
higher LSR versus OB subjects at 60 min (0.90 ± 0.25 vs. 0.70 ± 0.18 mg·cm2·min-1, p = 0.062).  
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The effect of hypohydration on LSR for both groups is presented in Figure 4B. The 
interaction between group and time was not significant (p = 0.939) and there were no differences 
between groups in LSR at any time point when HY versus EU (all p > 0.05).  
 There were no differences between N-OB and OB subjects in WBSR for either hydration 
condition (EU: 1.02 ± 0.29 vs. 1.03 ± 0.64, p = 0.978; HY: 0.77 ± 0.23 vs. 0.82 ± 0.33 L/h; 
Figure 5). Independent of group, WBSR was lower in the HY versus EU trials (i.e., main effect 
of hydration condition, p < 0.001). 
 SGA (glands/cm2) did not change over time in the EU trials (p = 0.529), nor was there a 
significant interaction between time and group (p = 0.864; Figure 6A). There were no differences 
between groups at 15 min (p > 0.05); however, N-OB tended to have higher SGA versus OB at 
30, 45, and 60 min (110 ± 93 vs. 35 ± 42, p = 0.072; 134 ± 113 vs. 43 ± 26, p = 0.060; and 146 ± 
137 vs. 44 ± 22 glands/cm2, p = 0.074).  
The effect of hypohydration on SGA for both groups is presented in Figure 7A. The 
interaction between group and time was not significant (p = 0.619) and there were no differences 
between groups in SGA at any time point when HY versus EU (all p > 0.05).  
 SGO (μg·gland-1·min-1) did not change over time in the EU trials (p = 0.084), nor was 
there a significant interaction between time and group (p = 0.243; Figure 6B). There were no 
differences between groups at 15, 30, or 60 min (all p > 0.05); however, OB tended to have 
higher SGO versus N-OB at 45 min (23 ± 11 vs. 11 ± 10 μg·gland-1·min-1, p = 0.061).  
The effect of hypohydration on SGO for both groups is presented in Figure 7B. The 
interaction between group and time was not significant (p = 0.745) and there were no differences 
between groups in SGO at any time point when HY versus EU (all p > 0.05). 
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Heart Rate (HR) and Mean Arterial Pressure (MAP) 
 In the EU trials, there was a significant interaction between group and time for HR from 
pre-exercise baseline to 45 min (p = 0.001; Figure 8A). OB subjects’ HR was higher versus N-
OB at 15, 30, and 45 min (165 ± 23 vs. 140 ± 26; 166 ± 20 vs. 145 ± 22; 165 ± 25 vs. 140 ± 21 
bpm; all p < 0.05). At 60 min, there was a tendency for OB subjects to have a higher HR versus 
N-OB (159 ± 29 vs. 137 ± 19 bpm, p = 0.097).  
The effect of hypohydration on changes in HR for both groups is presented in Figure 9A. 
Hypohydration did not affect the change over time (p = 0.473), nor was there a significant 
interaction between group and time (p = 0.450). When hypohydrated, HR was not significantly 
elevated in either group at 15, 30, or 45 min (all p > 0.05); however, there was a trend towards 
higher HR in N-OB versus OB subjects at 60 min (14 ± 15 vs. 3 ± 10 bpm, p = 0.062).  
In the EU trials, there was a significant main effect of time for MAP (p < 0.001), non-
significant effect of group (p = 0.114), and a trend towards a significant interaction between 
group and time from pre-exercise baseline to 45 min (p = 0.058; Figure 8B). MAP was lower in 
OB versus N-OB subjects at 30 min (79 ± 9 vs. 87 ± 6 mmHg, p = 0.032), but there were no 
other differences between groups at any other time point (all p > 0.05).  
The effect of hypohydration on MAP for both groups is presented in Figure 9B. The 
interaction between group and time was not significant (p = 0.640) and there were no differences 
between groups in MAP at any time point when HY versus EU (all p > 0.05).  
Discussion 
 In the present study, we investigated thermoregulatory responses in non-obese (N-OB) 
and obese (OB) males to exercise heat stress while either euhydrated (EU) or hypohydrated 
 26 
 
(HY). It was hypothesized that OB males would exhibit impaired thermoregulatory responses 
and hypohydration would further exacerbate these responses versus N-OB. Our results 
demonstrate similar cutaneous vasodilation and sweating responses between groups, independent 
of hydration status. When euhydrated, OB subjects had a significantly greater change in rectal 
temperature versus N-OB (Figure 1A), despite no differences in CVC, LSR, or whole body 
sweat rate (WBSR) (Figures 5). Interestingly, the elevated rectal temperature response typically 
observed when HY versus EU during exercise was present in N-OB but not OB subjects (Figure 
2A). These data suggest that euhydration is unable to prevent rectal temperature from increasing 
to levels achieved when hypohydrated in OB males during exercise heat-stress.  
Effect of obesity on thermoregulatory responses while euhydrated 
 Optimal functioning of thermoregulatory mechanisms are critical to maintaining 
appropriate thermal balance and preventing the onset of heat illness during exercise (23). This is 
primarily achieved via redistributing central blood volume to the periphery (i.e, skin) for heat 
dissipation via convection and increasing sweat output for evaporative heat loss (44). Vroman et 
al. reported significantly lower forearm blood flow (FBF; an index of skin blood flow) in obese 
versus lean subjects during exercise in a hot environment, despite similar esophageal and skin 
temperatures (51) and without manipulation of hydration status. It was hypothesized that 
alterations in FBF in the obese group may have been related to increased sympathetic 
vasoconstrictor activity to the skin circulation. Indeed, previous work has shown that a reduction 
in mean arterial pressure (MAP) induced via lower-body negative pressure leads to a baroreflex-
mediated skin vasoconstrictor response (8). Moreover, a considerable amount of evidence 
suggests that obesity is associated with increased basal sympathetic activation (3, 11, 30, 42) and 
altered baroreflex sensitivity (19, 48). In the present study, MAP while euhydrated was the same 
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in both N-OB (91 ± 10) and OB (91 ± 11 mmHg) groups at 15 min into the exercise bout, but 
decreased significantly between 15 and 30 min in OB (-12 ± 8) but not N-OB subjects (-4 ± 8 
mmHg; Figure 8B). Thus, it is possible that the significant reduction in MAP may have 
influenced baroreceptor-mediated vasoconstrictor activity in OB, although not to the extent 
where CVC was significantly impaired (Figure 3A). 
 In contrast with previous work (5, 6, 51), we did not observe differences between N-OB 
and OB in cutaneous vasodilation or sweating when euhydrated. Several recent investigations, 
however, reported similar findings to the current study (1, 18, 32). Possible discrepancies in the 
literature may be due to differences in physiological strain imposed by the environmental 
conditions (i.e., compensable versus uncompensable). Dervis et al. recently reported a higher 
core temperature in high- versus low-body fat male subjects during exercise in a compensable 
(~28°C) environment, with no differences in sweat rate between groups (18). Similarly, we also 
observed a greater change in rectal temperature in OB versus N-OB subjects, coupled with 
similar local and whole body sweat rates and cutaneous vasodilation. However, the explanation 
for similar cutaneous vasodilatory and sweating responses between groups, despite large 
differences in body temperature, is unclear. Given that skin blood flow and sweating increase to 
their maximum capacity concomitantly with increases in body temperature in order to maintain 
thermal homeostasis, OB should have exhibited greater CVC and/or sweat rate versus N-OB 
given their higher rectal temperature. Interestingly, this did not occur, which lead to OB storing 
considerably more heat versus N-OB (42.1 ± 14.5 vs. 25.8 ± 13.7 W·m-2), ultimately leading to a 
higher rectal temperature (Figure 1A). This suggests the possibility of impaired efferent and/or 
afferent signaling between the hypothalamus and the effector organ(s), impaired post-synaptic 
responses to appropriate efferent signaling from the hypothalamus, or some combination of 
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centrally- and peripherally-mediated responses leading to reduced maximal vasodilatory and 
sweating responses versus N-OB.  
 In addition to significant differences between subject groups in body mass and body fat, 
N-OB had higher specific heat capacity versus OB (Table 1), owing to the large differences 
between groups in adiposity. The higher proportion of lean mass in N-OB versus OB may have 
allowed for more efficient heat conductance from the core to the periphery, leading to improved 
capability of convective heat exchange. However, given the high, uncompensable ambient 
temperature used (~40°C), convective heat transfer would likely have made a minimal 
contribution to overall thermal balance due to the large negative thermal gradient between the 
skin and environment (~4-5°C). Thus, given similar metabolic heat production relative to body 
mass between groups, coupled with similar vasodilatory and sweating responses, the explanation 
for higher rectal temperature in OB versus N-OB when euhydrated remains unclear.  
Effect of hypohydration on thermoregulatory responses  
 While several studies have compared thermoregulatory responses between groups of 
dissimilar body mass and/or body fat during exercise (1, 5, 16, 18), this is the first known 
investigation to simultaneously assess the influence of hydration status. In non-obese individuals, 
the influence of hypohydration during exercise heat stress has been repeatedly demonstrated to 
lead to a higher core temperature versus a euhydrated condition (35, 40, 45, 46). This is likely 
due to perturbations in thermoregulatory mechanisms (i.e., skin blood flow and sweat rate) that 
typically accompany hypohydration (34, 36, 43). Interestingly, our data demonstrate a significant 
difference between groups in the rectal temperature response to hypohydration. The end exercise 
rectal temperature was significantly higher when HY (38.92 ± 0.36°C) versus EU (38.35 ± 
0.38°C) in N-OB, but not OB (38.72 ± 0.45 vs. 38.72 ± 0.45°C) subjects. Importantly, this is 
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despite both N-OB and OB groups starting and finishing the exercise protocol at the same level 
of hypohydration, confirmed via multiple variables (Table 2). This suggests that hypohydration 
appears to affect the rectal temperature response to a greater extent in N-OB versus OB. The 
reason(s) behind this varied response are not abundantly clear, but may be related to 
aforementioned possible impairments in centrally- and/or peripherally-mediated 
thermoregulatory responses in OB versus N-OB.  
 Consistent with previous investigations using non-obese subjects (21, 24), our results 
showed reductions in WBSR accompanying hypohydration, independent of group (Figure 5). 
Similar values of WBSR between groups are consistent with recent investigations comparing 
groups with vast differences in body fat (1, 18). Similarly, the change in LSR and CVC 
attributed to hypohydration was not different between groups versus a euhydrated condition. 
This suggests that during aerobic exercise in the heat, the added physiological stress of 
hypohydration is tolerated equally well in OB subjects compared to N-OB counterparts.  It 
should be noted, however, that this investigation used subjects with significant differences in 
body mass and body surface area, in addition to large differences in body fat. Thus, the degree to 
which each of these characteristics independently influenced WBSR, LSR, or CVC during 
exercise heat stress cannot be deduced. 
  Mean skin temperature (Tsk) significantly decreased throughout the exercise protocol in 
both groups and under both hydration conditions. Interestingly, hypohydration had a 
substantially different effect on this response between groups, with a lower Tsk accompanying 
hypohydration in N-OB subjects (-0.77 ± 1.18°C) compared to an increase in OB subjects (1.05 
± 0.72°C) at 60 min versus a euhydrated state (Figure 2B). While the decrease in Tsk over time is 
consistent with other investigations (32, 35, 37), it is unclear as to why Tsk in these groups 
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responded in opposite fashion when comparing their EU and HY trials. It could be assumed that 
the reduction in Tsk during exercise is representative of evaporative heat loss occurring, gradually 
cooling the skin’s surface. Given that rectal temperature was significantly elevated in 
hypohydrated N-OB versus EU, the lower Tsk when hypohydrated may be indicative of greater 
reliance on evaporative heat loss. In the OB, however, rectal temperature was not different 
between hydration conditions. Thus, the inability of Tsk to reach similar levels versus EU in OB 
may suggest differences between N-OB and OB in the manner hypohydration affects the balance 
between evaporative and convective modes of heat dissipation in uncompensable exercise heat-
stress.    
Conclusions 
 The present investigation examined thermoregulatory responses in N-OB and OB males 
during exercise in the heat while euhydrated and hypohydrated. Using an exercise protocol that 
allowed for equal amounts of metabolic heat production (Watts per kg body mass) between 
groups, our results indicate that starting and maintaining euhydration during exercise leads to a 
lower end-exercise rectal temperature for N-OB but not OB subjects. Hypohydration appears to 
affect N-OB to a greater extent versus OB, with N-OB subjects exhibiting a significantly higher 
rectal temperature when HY versus EU, but no difference between hydration conditions in OB. 
In addition, the added physiological stressor of hypohydration does not appear to affect 
cutaneous vasodilatory and sweating responses differently between N-OB and OB. These data 
suggest that OB males have some degree of impairment in thermoregulatory responses to 
increases in body temperature during exercise heat-stress when euhdyrated versus N-OB. While 
hypohydration leads to a higher rectal temperature in N-OB, it does not appear to further increase 
this in OB versus a euhydrated condition. Further investigation into the influence of hydration 
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status on thermoregulatory responses during exercise should seek to examine females, as well as 
other clinical populations that may be at increased risk of developing heat illness (i.e., 
individuals with Type II Diabetes).  
 
Conflicts of interest 
There are no conflicts of interest to declare.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 32 
 
References 
1. Adams J, Ganio MS, Burchfield JM, et al. Effects of obesity on body temperature in 
otherwise-healthy females when controlling hydration and heat production during exercise in the 
heat. Eur J Appl Physiol. 2015; 115(1):167-76. 
2. Adams WC, Mack GW, Langhans GW, Nadel ER. Effects of varied air velocity on sweating 
and evaporative rates during exercise. J Appl Physiol (1985). 1992; 73(6):2668-74. 
3. Alvarez GE, Beske SD, Ballard TP, Davy KP. Sympathetic neural activation in visceral 
obesity. Circulation. 2002; 106(20):2533-6. 
4. Armstrong L, Maresh C, Castellani J, et al. Urinary indices of hydration status. Int J Sport 
Nutr. 1994; 4(3):265. 
5. Bar-Or O, Lundegren H, Buskirk E. Heat tolerance of exercising obese and lean women. J 
Appl Physiol. 1969; 26:403-9. 
6. Bar-Or O, Lundegren H, Magnusson L, Buskirk E. Distribution of heat-activated sweat glands 
in obese and lean men and women. Human Biology. 1968:235-48. 
7. Bedno SA, Li Y, Han W, et al. Exertional heat illness among overweight US Army recruits in 
basic training. Aviat Space Environ Med. 2010; 81(2):107-11. 
8. Beiser GD, Zelis R, Epstein SE, Mason DT, Braunwald E. The role of skin and muscle 
resistance vessels in reflexes mediated by the baroreceptor system. J Clin Invest. 1970; 
49(2):225-31. 
9. Booth ML, Ainsworth BE, Pratt M, et al. International physical activity questionnaire: 12-
country reliability and validity. Med Sci Sports Exerc. 2003; 195(9131/03):3508-1381. 
10. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982; 
14(5):377-81. 
11. Brooks VL, Shi Z, Holwerda SW, Fadel PJ. Obesity-induced increases in sympathetic nerve 
activity: sex matters. Autonomic Neuroscience. 2015; 187:18-26. 
12. Bruning RS, Santhanam L, Stanhewicz AE, et al. Endothelial nitric oxide synthase mediates 
cutaneous vasodilation during local heating and is attenuated in middle-aged human skin. J Appl 
Physiol (1985). 2012; 112(12):2019-26. 
13. Cheuvront SN, Carter R, Montain SJ, Sawka MN. Daily body mass variability and stability 
in active men undergoing exercise-heat stress. Int J Sport Nutr Exerc Metab. 2004; 14:532-40. 
14. Chung NK, Pin CH. Obesity and the occurrence of heat disorders. Mil Med. 1996; 
161(12):739-42. 
 33 
 
15. Cook DB, O'Connor PJ, Eubanks SA, Smith JC, Lee M. Naturally occurring muscle pain 
during exercise: assessment and experimental evidence. Med Sci Sports Exerc. 1997; 29(8):999-
1012. 
16. Cramer MN, Jay O. Selecting the correct exercise intensity for unbiased comparisons of 
thermoregulatory responses between groups of different mass and surface area. J Appl Physiol 
(1985). 2014; 116(9):1123-32. 
17. Deren TM, Coris EE, Bain AR, Walz SM, Jay O. Sweating is greater in NCAA football 
linemen independently of heat production. Med Sci Sports Exerc. 2012; 44:244-52. 
18. Dervis S, Coombs GB, Chaseling GK, Filingeri D, Smoljanic J, Jay O. A comparison of 
thermoregulatory responses to exercise between mass-matched groups with large differences in 
body fat. J Appl Physiol (1985). 2016; 120(6):615-23. 
19. Dipla K, Zafeiridis A, Koidou I, Geladas N, Vrabas IS. Altered hemodynamic regulation and 
reflex control during exercise and recovery in obese boys. Am J Physiol Heart Circ Physiol. 
2010; 299(6):H2090-6. 
20. Du Bois D, Du Bois EF. Clinical calorimetry: tenth paper a formula to estimate the 
approximate surface area if height and weight be known. Arch Intern Med. 1916; 17(6_2):863-
71. 
21. Ekblom B, Greenleaf CJ, Greenleaf JE, Hermansen L. Temperature regulation during 
exercise dehydration in man. Acta Physiol Scand. 1970; 79(4):475-83. 
22. Engell DB, Maller O, Sawka MN, Francesconi RN, Drolet L, Young AJ. Thirst and fluid 
intake following graded hypohydration levels in humans. Physiol Behav. 1987; 40(2):229-36. 
23. Epstein Y, Roberts W. The pathopysiology of heat stroke: an integrative view of the final 
common pathway. Scand J Med Sci Sports. 2011; 21(6):742-8. 
24. Fortney SM, Nadel ER, Wenger CB, Bove JR. Effect of blood volume on sweating rate and 
body fluids in exercising humans. J Appl Physiol Respir Environ Exerc Physiol. 1981; 
51(6):1594-600. 
25. Gagnon D, Dorman LE, Jay O, Hardcastle S, Kenny GP. Core temperature differences 
between males and females during intermittent exercise: physical considerations. Eur J Appl 
Physiol. 2009; 105(3):453-61. 
26. Gagnon D, Ganio MS, Lucas RA, Pearson J, Crandall CG, Kenny GP. Modified iodine-paper 
technique for the standardized determination of sweat gland activation. J Appl Physiol (1985). 
2012; 112(8):1419-25. 
27. Gallagher D, Heymsfield SB, Heo M, Jebb SA, Murgatroyd PR, Sakamoto Y. Healthy 
percentage body fat ranges: an approach for developing guidelines based on body mass index. 
Am J Clin Nutr. 2000; 72(3):694-701. 
 34 
 
28. Geddes L, Baker L. The specific resistance of biological material—a compendium of data for 
the biomedical engineer and physiologist. Medical and biological engineering. 1967; 5(3):271-
93. 
29. Gore CJ, Hopkins WG, Burge CM. Errors of measurement for blood volume parameters: a 
meta-analysis. J Appl Physiol (1985). 2005; 99(5):1745-58. 
30. Grassi G, Seravalle G, Cattaneo BM, et al. Sympathetic activation in obese normotensive 
subjects. Hypertension. 1995; 25(4 Pt 1):560-3. 
31. Kavouras SA. Assessing hydration status. Curr Opin Clin Nutr Metab Care. 2002; 5(5):519-
24. 
32. Limbaugh JD, Wimer GS, Long LH, Baird WH. Body fatness, body core temperature, and 
heat loss during moderate-intensity exercise. Aviat Space Environ Med. 2013; 84(11):1153-8. 
33. Malik VS, Willett WC, Hu FB. Global obesity: trends, risk factors and policy implications. 
Nature Reviews Endocrinology. 2013; 9(1):13-27. 
34. Montain SJ, Coyle EF. Fluid ingestion during exercise increases skin blood flow independent 
of increases in blood volume. J Appl Physiol (1985). 1992; 73(3):903-10. 
35. Montain SJ, Coyle EF. Influence of graded dehydration on hyperthermia and cardiovascular 
drift during exercise. J Appl Physiol (1985). 1992; 73(4):1340-50. 
36. Montain SJ, Latzka WA, Sawka MN. Control of thermoregulatory sweating is altered by 
hydration level and exercise intensity. J Appl Physiol (1985). 1995; 79(5):1434-9. 
37. Nakayama T, Ohnuki Y, Niwa K. Fall in skin temperature during exercise. Jpn J Physiol. 
1977; 27(4):423-37. 
38. Nilsson GE, Tenland T, Öberg PÅ. Evaluation of a laser Doppler flowmeter for measurement 
of tissue blood flow. Biomedical Engineering, IEEE Transactions on. 1980(10):597-604. 
39. Nishi Y. Measurement of thermal balance in man. Bioengineering, thermal physiology and 
comfort. 1981:29-39. 
40. Pitts G, Johnson R, Consolazio F. Work in the heat as affected by intake of water, salt and 
glucose. Am J Physiol. 1944; 142. 
41. Ramanathan NL. A New Weighting System for Mean Surface Temperature of the Human 
Body. J Appl Physiol. 1964; 19:531-3. 
42. Rossi M, Marti G, Ricordi L, et al. Cardiac autonomic dysfunction in obese subjects. Clin Sci 
(Lond). 1989; 76(6):567-72. 
43. Sawka MN. Physiological consequences of hypohydration: exercise performance and 
thermoregulation. Med Sci Sports Exerc. 1992; 24(6):657-70. 
 35 
 
44. Sawka MN, Wenger CB, Pandolf KB. Thermoregulatory responses to acute exercise‐heat 
stress and heat acclimation. Comprehensive physiology. 2011. 
45. Sawka MN, Toner MM, Francesconi RP, Pandolf KB. Hypohydration and exercise: effects 
of heat acclimation, gender, and environment. J Appl Physiol Respir Environ Exerc Physiol. 
1983; 55(4):1147-53. 
46. Sawka MN, Young AJ, Francesconi RP, Muza SR, Pandolf KB. Thermoregulatory and blood 
responses during exercise at graded hypohydration levels. J Appl Physiol (1985). 1985; 
59(5):1394-401. 
47. Schmidt W, Prommer N. The optimised CO-rebreathing method: a new tool to determine 
total haemoglobin mass routinely. Eur J Appl Physiol. 2005; 95(5-6):486-95. 
48. Skrapari I, Tentolouris N, Perrea D, Bakoyiannis C, Papazafiropoulou A, Katsilambros N. 
Baroreflex sensitivity in obesity: relationship with cardiac autonomic nervous system activity. 
Obesity. 2007; 15(7):1685-93. 
49. Stolwijk JA. Mathematical models of thermal regulation. Ann N Y Acad Sci. 1980; 335(1):98-
106. 
50. Toner MM, Sawka MN, Foley ME, Pandolf KB. Effects of body mass and morphology on 
thermal responses in water. J Appl Physiol (1985). 1986; 60(2):521-5. 
51. Vroman N, Buskirk E, Hodgson J. Cardiac output and skin blood flow in lean and obese 
individuals during exercise in the heat. J Appl Physiol. 1983; 55(1):69-74. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 36 
 
Figure Captions 
Figure 1. Changes in rectal temperature (Trec; A), mean skin temperature (Tsk; B) and mean body 
temperature (Tb; C) in non-obese (N-OB) and obese (OB) subjects while euhydrated. *significant 
difference between groups (p < 0.05).  
Figure 2. Changes in rectal temperature (Trec; A), mean skin temperature (Tsk; B) and mean body 
temperature (Tb; C) in non-obese (N-OB) and obese (OB) subjects calculated as the difference 
between hypohydrated (HY) versus euhydrated (EU) conditions. *significant difference between 
groups (p < 0.05).  
Figure 3. Changes in cutaneous vascular conductance (CVC; A) and local sweat rate (LSR; B) in 
non-obese (N-OB) and obese (OB) subjects while euhydrated. No significant differences 
between groups at any time point (all p > 0.05).  
Figure 4. Changes in cutaneous vascular conductance (CVC; A) and local sweat rate (LSR; B) in 
non-obese (N-OB) and obese (OB) subjects calculated as the difference between hypohydrated 
(HY) versus euhydrated (EU) conditions. No significant differences between groups at any time 
point (all p > 0.05).  
Figure 5. Whole body sweat rate (WBSR) in non-obese (N-OB) and obese (OB) subjects while 
euhydrated (EU) and hypohydrated (HY). *significantly different from HY condition, 
independent of group (p < 0.05). 
Figure 6. Changes in sweat gland activation (SGA; A) and sweat gland output (SGO; B) in non-
obese (N-OB) and obese (OB) subjects while euhydrated. No significant differences between 
groups at any time point (all p > 0.05).  
Figure 7. Changes in sweat gland activation (SGA; A) and sweat gland output (SGO; B) in non-
obese (N-OB) and obese (OB) subjects calculated as the difference between hypohydrated (HY) 
versus euhydrated (EU) conditions. No significant differences between groups at any time point 
(all p > 0.05).  
Figure 8. Changes in heart rate (HR; A) and mean arterial pressure (MAP; B) in non-obese (N-
OB) and obese (OB) subjects while euhydrated. *significant difference between groups (p < 
0.05).  
Figure 9. Changes in heart rate (HR; A) and mean arterial pressure (MAP; B) in non-obese (N-
OB) and obese (OB) subjects calculated as the difference between hypohydrated (HY) versus 
euhydrated (EU) conditions. *significant difference between groups (p < 0.05). 
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Abstract 
Obesity is associated with microvascular dysfunction, which can precede hypertension 
and cardiovascular disease. During whole-body heat stress hypohydration attenuates cutaneous 
vasodilation and sweating responses, but it is unknown if this generalized response is due to 
post-synaptic dysfunction. Further, it is unknown how thermoregulatory responses may be 
altered in hypohydrated obese (OB) versus non-obese (N-OB) individuals. Purpose: To 
determine the effect of hypohydration on post-synaptic cutaneous vasodilatory and sweating 
responses in OB and N-OB males when euhydrated (EU) and hypohydrated (HY). Methods: In a 
randomized design, 10 N-OB (body fat [BF] 30.1 ± 39%) and 10 OB (BF 14.3 ± 3.3%) males 
were instrumented for forearm microdialysis when EU and HY. Changes in cutaneous vascular 
conductance (CVC) in response to incremental intradermal infusion of the endothelium-
independent vasodilator sodium nitroprusside (SNP, 5 x 10-8 to 5 x 10-2 M) and the endothelium-
dependent vasodilator methacholine chloride (MCh, 1 x 10-7 to 1 x 10-1 M) were assessed by 
laser Doppler flowmetry. Local sweat rate (LSR) was simultaneously assessed at the MCh site 
via ventilated capsule.  At the end of the 7th dose, maximal CVC was elicited by delivering a 
maximal dose of SNP for 30 min to both sites with simultaneous local heating (~44°C) at the 
SNP site. Dose-response curves were compared between groups and hydration condition using 
an extra sum of squares F-test. Results: When EU, Log EC50 of MCh-mediated CVC was not 
different between N-OB versus OB subjects (-3.04 ± 0.12 vs. -2.98 ± 0.19 Log [MCh] M, p = 
0.841). Within each group, EU and HY MCh-mediated Log EC50 did not differ (p > 0.05). Log 
EC50 of SNP-mediated CVC was higher in EU OB versus N-OB (-1.69 ± 0.17 vs. -2.13 ± 0.06 
Log [SNP] M, p = 0.014). EU and HY SNP-mediated Log EC50 did not differ within groups (p > 
0.05). LSR response did not differ between group or hydration condition (p > 0.05). Conclusion: 
 53 
 
Impaired endothelium-independent vasodilation was present in OB versus N-OB males, with no 
differences between groups in endothelium-dependent vasodilation or sweating responses. 
Hypohydration tended to impair endothelium-independent vasodilation in N-OB but not OB. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 54 
 
Introduction 
 Increases in body and skin temperature are accompanied by subsequent increases in 
cutaneous vasodilation and sweating in efforts to dissipate heat and maintain thermal 
homeostasis (3, 26). While these responses are primarily mediated via sensory inputs to the 
hypothalamus, the post-synaptic (i.e., peripherally-mediated) contribution to these responses is 
less understood. Thus, the relative influence of microvascular function on cutaneous vasodilatory 
and sweating responses is unclear.  
 Microvascular dysfunction has been associated with cardiovascular disease, stroke, and 
glucose intolerance (14, 23). Further, significant changes in macro- and micro-circulation are 
known to accompany obesity (33). Previous investigations have shown attenuated endothelium-
dependent (8, 15, 31) and endothelium-independent (24) responses to various methods of 
assessment in obese versus non-obese counterparts. However, the effect of obesity on these 
responses has not been explored to the same extent in the microcirculation.  
 Whole-body heat stress allows for assessment of cutaneous vasodilation and sweating in 
response to increases in body and skin temperature (i.e., mediated via efferent signaling of the 
central nervous system [CNS]). However, onsets for cutaneous vasodilatory and sweating can be 
modified in the absence of known CNS modulation (19, 29), suggesting the possibility that these 
responses may be modified by localized changes at the effector organ (10). Hypohydration is 
typically characterized by a reduction in plasma volume leading to plasma hyperosmolality (25, 
27). Growing evidence suggests a prominent role for chronic hypohydration in the development 
of medical maladies including chronic kidney disease and nephrolithiasis (5, 30, 32). Moreover, 
acute hypohydration attenuates cutaneous vasodilatory and sweating responses during whole-
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body heat stress (22, 27). However, it is unknown if these attenuated responses with 
hypohydration are due to altered post-synaptic function.  
 More recently, the use of intra-dermal microdialysis has been used for assessment of 
cutaneous vasodilatory and sweating responses (i.e., microvascular function) in a variety of 
healthy and clinical populations (6, 7, 11) During an assessment of microvascular function in 
obese and non-obese males, Patik et al. reported an attenuated endothelium-independent 
response in obese compared to non-obese, while endothelium-dependent vasodilation was 
preserved (24). However, the study did not compare local sweat rate (LSR) responses between 
groups, nor did it control for hydration status as a potential modifying variable. 
 Therefore, the aim of the present study was two-fold: 1) to determine if impairments in 
cutaneous vasodilatory and sweating responses are present in obese (OB) versus non-obese (N-
OB) males while euhydrated, and 2) to determine how these responses may be altered in 
hypohydrated OB versus N-OB males during incremental intradermal infusion of endothelium-
dependent and endothelium-independent vasodilators. We hypothesized that impairments in 
cutaneous vasodilatory and sweating responses present in OB subjects while euhydrated would 
be further exacerbated while hypohydrated versus their N-OB counterparts.   
Materials and Methods 
Subjects 
Twenty healthy adult males from the University and surrounding community volunteered 
to participate in the study. In order to be considered eligible, subjects were required to have a 
stable body weight (i.e., not actively trying to lose or gain weight), be willing to abstain from 
caffeine and alcohol on lead-in and testing days, be free of any medications or supplements that 
may affect body weight or fluid balance, be free of any metabolic and/or cardiovascular 
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disorders, and abstain from physical activity beyond normal activities of daily living during a 48-
h experimental period. All subjects were required to provide written informed consent prior to 
participation through signing a document that was approved by the University’s Institutional 
Review Board.  
During a screening visit, body fat (BF) percentage was determined via dual-energy X-ray 
absorptiometry (DXA; Lunar Prodigy, General Electric®, Madison, WI). Subjects with a BF 
<18% were considered non-obese (N-OB; n = 10) and those ≥26% obese (OB; n = 10) (12). 
Subject demographic data are presented in Table 1. Subjects had their height measured using a 
standard stadiometer (Seca 216 stadiometer, Chino, CA) and nude body mass (BM) using a 
platform scale (Health-O-Meter, Model 349KLX, Alsip, IL). These values were used to calculate 
body mass index (BMI). A digital bathroom scale was provided to subjects (High Accuracy 
Bathroom Scale, BalanceFrom LLC, China) to measure morning euhydrated BM during a 3-day 
baseline period to use for later calculations of BM change (4). 
Experimental Design 
Subjects completed two trials separated by a minimum of 72 h. In a randomized order, 
skin microdialysis (MD) was performed while subjects were either euhydrated (EU) or 
hypohydrated (HY). In order to facilitate hypohydration, 48-h before reporting to the laboratory 
for MD, subjects were restricted to 237 ml of drinking water intake. Twenty-four hours prior to 
MD, subjects completed 60 min of moderate intensity cycling on a mechanically-braked cycle 
ergometer (Veletron, RacerMate Inc., Seattle, WA) in a hot environment. Fluids were not 
provided during the exercise protocol and subjects remained fluid restricted following 
completion of exercise, receiving a further 237-473 ml of drinking water until returning to the 
laboratory the following day for MD. For the EU trial, subjects consumed an adequate amount of 
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drinking water (45 ml·kg-1) 48-h prior to MD, and were provided fluids throughout the exercise 
protocol in order to replace sweat losses. Following exercise, subjects were encouraged to drink 
fluids to maintain euhydration for MD the next day.  
Hydration Status Assessment 
Upon arrival to the laboratory for the MD protocol, nude body mass was measured 
(Health-o-meter digital scale, model 349KLX, Pelstar LLC, Alsip, IL, USA). Body mass change 
(∆BM) was calculated as the difference between subjects’ 3-day euhydrated BM baseline and 
BM upon arrival to the laboratory. Subjects provided a urine sample which was analyzed for USG 
using a hand-held refractometer (Master-SUR/NM, ATAGO, Japan), osmolality (Uosm), and 
color (Ucol). Urine osmolality was measured in duplicate using freezing point depression 
osmometry (Model 3250, Advanced Instruments Inc., Norwood, MA). Color was assessed in a 
well-lit room using the eight-level color scale where the sample was in a glass tube against a 
plain white background (1, 18). 
 Blood samples were collected via an intravenous catheter (SurFlash®, Terumo 
Corporation, Tokyo, Japan) placed in a superficial forearm vein while subjects were in a reclined 
position in a phlebotomy chair for at least 20 min. Whole blood was drawn into a 6 ml 
Vacutainer collection tube with EDTA additive for analysis of hemoglobin (Hb), hematocrit 
(Hct), and carboxyhemoglobin concentration (HbCO%). Serum osmolality (Sosm) was measured 
in duplicate fresh samples using freezing point depression osmometry (Model 3250, Advanced 
Instruments Inc., Norwood, MA). Hemoglobin was measured in triplicate 10 µl samples using a 
HemoCueHb 201+ analyzer (HemoCue AB, Angelholm, Sweden). Hematocrit was analyzed in 
triplicate 35 µl samples drawn into microcapillary tubes, spun down in a microcentrifuge for 
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three minutes at 12,000 rpm (UNICO model C-MH30, Dayton, NJ), and values measured on a 
Damon Micro-Capillary Reader (Needham Heights, MA).  
Red cell volume (RCV), plasma volume (PV), and blood volume (BV) were determined 
using the optimized CO-rebreathing method described by Schmidt and Prommer (28). A baseline 
blood sample was drawn and analyzed for HbCO% using an ABL80 FLEX OSM-3 co-oximeter 
(Radiometer, Denmark). Additional blood samples were drawn and analyzed at 6 and 8 minutes 
after beginning the rebreathing procedure, with an average of these measures (i.e., 7 minutes) 
being used for the calculation of ∆HbCO%. A portable CO analyzer with parts-per-million 
sensitivity (Pac 7000, Dräger Safety AG & Co. KGaA, Lübeck, Germany) was used to monitor 
potential gas leaks during the rebreathing procedure and to determine CO concentration 
remaining in the lungs and breathing bag following completion of the procedure. RCV, PV, and 
BV were then calculated using baseline values of [Hb] and Hct (described previously) using the 
following formulas (13): 
RCV = BV * Hct 
PV = BV – RCV 
BV = RCV / [Hb] 
Relative PV and BV (PVrel and BVrel, respectively) were calculated by dividing PV and BV by 
pre-trial BM. Due to technical difficulties, data were unable to be collected on some subjects. 
Results are presented as N-OB (n = 8) and OB (n = 6).  
Microdialysis Protocol 
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Prior to inserting the microdialysis membranes, an ice pack was placed on the subject’s 
arm for ~10 minutes to minimize hyperemia (16). Two intradermal MD probes (MD-2000, 
BASi® Inc., West Lafayette, IN) were then inserted into the left dorsal forearm by advancing a 
23-gauge needle 15-20 mm through the dermal layer, 1-2 mm below the skin’s surface. The 
probe was passed through the lumen of the needle and the needle was then withdrawn, leaving in 
place a 1 cm dialysis membrane (6). The MD probes were perfused with 0.9 % NaCl saline at a 
rate of 4.0 µl·min-1 via a perfusion pump (Pump 11 Pico Plus Elite, Harvard Apparatus, 
Holliston, MA) for 90 minutes while the hyperemic response from insertion subsided. During 
this time, the proximal MD site was instrumented for measurement of skin blood flow flux 
(SkBF; via laser-Doppler flowometry), with the laser being held in place by a ventilated capsule 
(for simultaneous measurement of local sweat rate [LSR; described below]). The distal MD site 
was instrumented for SkBF with the laser being held in place by a local heater (Perflux System 
5000, Perimed, Ardmore, PA).  
Following this initial 90 minute period, the drug infusion protocol commenced. At the 
proximal MD site, the endothelium-dependent vasodilator methacholine chloride (MCh) was 
perfused through the membrane starting at a concentration of 1 x 10-7 M and increasing in 10-
fold increments to a maximal dose of 1 x 10-1 M. At the distal MD site, the endothelium-
independent vasodilator sodium nitroprusside (SNP) was perfused through the membrane 
starting at a concentration of 5 x 10-8 M and increasing in 10-fold increments to a maximal dose 
of 5 x 10-2 M. The drugs were infused for 1 minute at a rate of 100 µl·min-1 before being 
switched to a rate of 4 µl·min-1 for an additional 4 minutes so that each dose was administered 
for at least 5 minutes (6). Beginning at 4 minutes into each dose, blood pressure was measured in 
duplicate via automated auscultation of the right brachial artery (Tango+; SunTech Medical, Inc., 
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Morrisville, NC). Mean arterial pressure (MAP) was later calculated ([1/3*systolic blood 
pressure] + [2/3*diastolic blood pressure]) for subsequent calculations of cutaneous vascular 
conductance (CVC).  
Skin blood flow flux was continuously recorded through the protocol via an integrated 
laser-Doppler flowmeter probe (Moor Instruments Inc., Wilmington, DE) at both sites. Changes 
in cutaneous vasomotor activity, expressed as CVC, were calculated by dividing skin blood flow 
flux by MAP and reported as a percentage of maximal CVC (i.e., %CVCmax). At the end of the 
maximum dose of each drug, maximal vasodilation was elicited by delivering a maximal dose (5 
x 10-2 M) of SNP for 30 minutes at both sites. Maximal CVC at the SNP site was taken from the 
highest SkBF flux/MAP recorded during the maximal SNP dose with simultaneous local heating 
of the skin for at least 30 minutes (until a plateau occurred) at ~44°C (2). Maximal CVC at the 
MCh site was taken from the highest SkBF flux/MAP recorded over the protocol.  
LSR was measured at the MCh site using a 2.85 cm2 plastic ventilated capsule held on 
the skin by adhesive tape. Dry nitrogen gas was supplied through the capsule at a rate of 0.3 
l·min-1. The absolute humidity (g/m3) and ambient temperature from the effluent air of the 
capsule were monitored by a humidity and temperature sensor (HMT333, Vaisala, Woburn, MA) 
and LSR (mg·cm-2·min-1) was calculated as LSR = ([flow rate in mg3/min·absolute humidity in 
gm/3] / [capsule surface area in cm2])·1000.   
Heart rate (HR) was recorded prior to blood pressure measurement at the end of each 
dose via a 3-lead electrocardiogram (Tango+; SunTech Medical, Inc., Morrisville, NC, USA). 
Local skin temperature was at an exposed area of the forearm between the MD sites (Tsk) using a 
~1 mm diameter thermocouple (Physitemp, Clifton, NJ). 
Statistical Procedures 
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 During each trial, SkBF, LSR, and Tsk were continuously recorded using data acquisition 
software (LabChart 7, ADInstruments, Colorado Springs, CO) at a frequency of 50 Hz. Values of 
these variables at each dose of MCh and SNP were determined from an average of two separate 
30 second averages of data recorded during blood pressure measurement (between ~4-5 minutes 
of each dose). Dose response curves were created using the %CVCmax calculated at each dose 
and compared via an extra sum of squares F-test (GraphPad Prism 6, GraphPad Software, La 
Jolla, CA). The dose that elicited half of the maximal response (Log EC50) at each site was 
analyzed between group and between hydration condition curves. Thus, expressing the data as 
%CVCmax isolates the independent effect of hydration status and obesity. Paired and independent 
t-tests were used to compare hydration biomarkers, baseline, and maximal CVC/LSR responses 
within and between groups.  
One subject in the OB group was excluded from analyses at the MCh site due to a 
technical error with the microdialysis membrane at this site and a different OB subject was 
excluded from analyses at the SNP site for the same reason. 
A 2 (hydration) x 8 (time) repeated measures ANOVA was used to compare changes in 
Tsk within groups between hydration conditions. All ANOVA and t-test analyses were performed 
using SPSS v. 23 (IBM Corporation, Somers, NY).  Greenhouse-Geisser corrections and follow 
up tests were performed as necessary. 
Descriptive data and hydration measures are reported as mean ± SD. CVC and LSR data 
are reported as mean ± SE. An alpha less than 0.05 defined significance for all tests. 
Results 
Hydration Status Measures 
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 Measures of ∆BM, USG, Uosm, Ucol, and Sosm are presented in Table 2. As intended, there 
was a main effect of hydration condition, with greater ∆BM, USG, Uosm, Ucol, and Sosm in the HY 
versus EU trials, independent of group (all p < 0.001). There were no differences between groups 
within hydration conditions (all p > 0.05).   
 Measures of RCV, PV, and BV are presented in Table 3. Relative PV and BV (PVrel and 
BVrel, respectively) were both higher in N-OB versus OB subjects, independent of hydration 
condition (p < 0.05). There were no differences between groups in RCV, PV, or BV in either 
hydration condition (all p > 0.05). Likewise, the HY-EU change was not different between or 
within groups.   
Endothelium-dependent Cutaneous Vascular Conductance (CVC) 
 Baseline (%CVCmax) and maximal CVC was not different between the EU versus HY 
condition in N-OB (Base: 30.7 ± 4.7 vs. 38.9 ± 6.9%; Max:  76.4 ± 5.9 vs. 78.8 ± 5.8%) or OB 
(Base: 25.9 ± 5.3 vs. 26.4 ± 4.4%; Max:  82.0 ± 7.6 vs. 83.7 ± 3.9%) (all p > 0.05). Within each 
hydration condition, baseline and maximal CVC were not different between groups (p > 0.05).  
Percentage of maximum CVC responses to incremental doses of MCh in the EU trial 
were not different between groups, with a similar Log EC50 in N-OB and OB (Figure 1A). Log 
EC50 values when EU versus HY within N-OB and OB groups were also similar (Figures 2A and 
2B, respectively).  
Endothelium-independent Cutaneous Vascular Conductance (CVC) 
 Baseline (%CVCmax) and maximal CVC was not between the EU versus HY condition 
within OB subjects (Base: 24.1 ± 7.8 vs. 19.5 ± 3.7%; Max: 48.3 ± 9.2 vs. 44.2 ± 9.5%, both p > 
0.05) but tended to be lower in N-OB when EU versus HY (Base: 21.8 ± 2.7 vs.  30.7 ± 3.9%, p 
= 0.061; Max: 48.8 ± 6.8 vs. 65.9 ± 6.2%, p = 0.064).  
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In the EU condition, OB subjects had a higher Log EC50 versus N-OB in response to 
incremental doses of SNP (Figure 3). Hydration status appeared to affect groups differently, with 
a trend towards a higher Log EC50 when EU versus HY (p = 0.062) in N-OB but not OB subjects 
(p = 0.242) (Figures 4A and 4B, respectively).  
Local Sweat Rate (LSR) 
 Baseline and maximal LSR was not different between the EU versus HY condition in OB 
(Base: 0.14 ± 0.01 vs. 0.14 ± 0.01 mg·cm2·min-1; Max:  0.23 ± 0.02 vs. 0.21 ± 0.02 mg·cm2·min-
1) (all p > 0.05). Baseline LSR was not different between EU versus HY in N-OB (Base: 0.16 ± 
0.01 vs. 0.15 ± 0.01 mg·cm2·min-1, p = 0.424) but there was a trend towards lower maximal LSR 
when EU versus HY (0.25 ± 0.03 vs. 0.30 ± 0.03 mg·cm2·min-1, p = 0.050). Within the EU and 
HY conditions, baseline LSR was not different between groups (p > 0.05); however, N-OB had a 
higher maximal LSR versus OB when HY (p = 0.020).   
 In the EU condition, LSR responses to incremental doses of MCh were not different 
between groups (Figure 5). Similarly, there were no differences in Log EC50 between groups 
when EU (p = 0.299) or HY (p = 0.179; Figures 6A and 6B, respectively).  
Local Skin Temperature (Tsk) 
 There were small increases in Tsk over time in the EU (p = 0.004) trial in both N-OB and 
OB subjects (Base: 32.2 ± 1.5 and 32.8 ± 1.7°C; End: 32.8 ± 1.2 and 33.6 ± 1.1°C, respectively); 
however, this change was not dependent on group (p = 0.490). Similarly, Tsk increased over time 
in the HY trial (p < 0.001) in both N-OB and OB subjects (Base: 32.3 ± 1.7 and 32.0 ± 1.2°C; 
End: 33.0 ± 1.0 and 32.6 ± 1.4°C) but this change was not dependent on group (p = 0.606). Tsk 
was not different between groups at any time point in either the EU or HY condition (all p > 
0.05).  
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Discussion 
In this study we investigated post-synaptic cutaneous vasodilatory and sweating 
responses to intradermal infusion of vasoactive compounds in non-obese (N-OB) and obese (OB) 
males while euhydrated (EU) and hypohydrated (HY). We hypothesized that OB males would 
have attenuated responses versus N-OB counterparts while EU, and that these attenuated 
responses would be further impaired when HY. Our data demonstrate similar endothelium-
dependent cutaneous vascular conductance (CVC) between N-OB and OB subjects, independent 
of hydration status, in response to intradermal infusion of MCh. The higher Log EC50 in response 
to SNP suggests attenuated endothelium-independent CVC in OB versus N-OB subjects when 
EU but hypohydration only affected this response in N-OB. Neither body type or hydration 
status affected endothelium-dependent sweating responses, with similar LSR in all conditions. 
These data suggest that hypohydration affects endothelium-independent vasodilation in N-OB 
but not OB males. 
Effect of obesity on post-synaptic cutaneous vasodilation and sweating while euhydrated 
Obesity is associated with impairments in microvascular function, with previous 
investigations demonstrating attenuated endotheium-dependent (8, 15, 31) and independent (24) 
vasodilatory responses versus non-obese individuals using various methods of drug delivery. 
Until recently, however, differences in post-synaptic responses between obese and non-obese 
had not been investigated. Patik et al. compared vasdodilatory (CVC) responses between N-OB 
and OB males, reporting similar endothelium-dependent CVC between groups but impaired 
endothelium-independent CVC in OB subjects (24). Results from the current study further 
support this early study, as OB individuals required a significantly higher dose of SNP to elicit 
50% of the maximal CVC response versus N-OB, suggesting impaired endothelium-independent 
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vasodilation (Figure 3), with no differences between groups in endothelium-dependent CVC 
(Figure 1). Given that SNP acts as a nitric oxide (NO) donor, impaired endothelium-independent 
vasodilation in the OB subjects suggests modification of NO action on the microvasculature, 
possibly attenuating the release of NO from the endothelium. However, contrary to some other 
investigations (8, 15, 31), we did not observe impaired endothelium-dependent vasodilation in 
OB subjects. This suggests that preserved endothelium-dependent vasodilation in the present 
study (despite impaired endothelium independent vasodilation) may have been modified through 
the release of other vasoactive substances (24), such as prostaglandins or endothelial derived 
hyperpolarizing factor (EDHF) (17, 20, 21). In addition to cutaneous vasodilation, we also 
investigated potential differences between groups in sweating (LSR) responses to intradermal 
infusion of MCh. The Log EC50 and maximal LSR was similar between groups when EU, 
suggesting obesity does not affect post-synaptic control of sweating while euhydrated.  
Effect of hypohydration on post-synaptic cutaneous vasodilation and sweating 
Attenuated cutaneous vasodilatory and sweating responses at the whole-body level 
accompanying hypohydration have been previously observed (22, 27). However, this is the first 
known investigation to directly assess the effect of hypohydration on microvascular function. 
While MCh-mediated CVC was unaffected by hypohydration in either group (Figures 3A and 
3B), there was a trend towards a higher Log EC50 for SNP in hypohydrated versus euhydrated N-
OB (Figure 4A) but not OB subjects. This suggests that hypohydration attenuates the 
endotheium-independent vasodilatory response in N-OB but not OB individuals. Importantly, 
both groups were at similar levels of hypohydration as indicated by multiple urinary and 
circulatory indices (Table 2). For example, both groups also had similar absolute plasma and 
blood volumes, with similar changes in these parameters accompanying hypohydration (Table 
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3). The tendency of higher baseline and maximal CVC in hypohydrated N-OB subjects versus 
their euhydrated state is contrary to our hypothesis, but is similar to other findings. For example 
Gagnon et al. observed elevated CVC following intradermal infusion of hypertonic saline (10). 
Infusion of hypertonic saline likely lead to hyperosmolality of the interstitial fluid space, 
mimicking the effect of whole-body hypohydration that was induced in the current study. 
Interestingly, this finding from Gagnon et al. was in contrast to a previous investigation showing 
attenuated cutaneous vasodilation during local heating following intradermal infusion of 
hypertonic saline (9). In the current study, the mechanism(s) behind elevated baseline and 
maximal CVC response to SNP infusion in hypohydrated N-OB subjects remains unclear. If 
elevated osmolality of the interstitium occurred as a result of hypohydration-induced plasma 
hyperosmolality, it is unknown why this would affect cutaneous vasodilation in N-OB, but not 
similarly hypohydrated OB individuals. Given that we observed an attenuated endothelium-
independent CVC response in euhydrated OB, it is possible that the apparent differences in 
microvascular function between groups subsequently affected the response to hypohydration. 
Further investigation into the mechanism(s) behind attenuated SNP-mediated vasodilation 
accompanying hypohydration is warranted.  
In addition to examining the effect of hypohydration on cutaneous vasodilation in N-OB 
and OB, we simultaneously compared the influence of hypohydration on post-synaptic sweating 
responses. Endothelium-dependent (i.e., MCh-mediated) LSR responses were similarly affected 
by hypohydration in N-OB and OB, with similar Log EC50 values between EU and HY trials in 
each group (Figures 5 and 6). However, within the HY condition, N-OB had a significantly 
higher maximal LSR versus OB (0.30 ± 0.03 vs. 0.21 ± 0.02 mg·cm2·min-1). The exact 
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mechanism(s) behind a reduced maximal LSR in hypohydrated OB versus N-OS is unclear and 
warrants further investigation. 
Limitations 
Skin temperature can modify cutaneous vasodilatory and sweating responses independent 
from any changes in core body temperature. Given that we were examining changes in these 
parameters without modifying core body temperature, skin temperature should ideally be the 
same when comparing different populations under different physiological conditions. Dual 
assessment of both CVC and LSR at the MCh site limited our ability to clamp skin temperature 
(Tsk) at the drug delivery sites at a fixed point. However, Tsk prior to starting drug infusion and 
subsequent changes throughout the protocol were not different between group or hydration 
condition, suggesting that this likely had negligible influence on CVC and LSR responses.  
While our OB subjects could certainly be classified as such given their high body mass 
and fat percentage, it should be noted that they were still a relatively young and healthy sample, 
free of any cardiovascular or metabolic disorders. Due to the exercise-heat stress trial the 
subjects performed 24-h prior to reporting for the present study, we required individuals with 
sufficient aerobic fitness to be able to complete the protocol. In doing so, this eliminated 
potential subjects with higher adiposity and lower aerobic fitness that may have otherwise 
qualified. Future studies should seek to examine the relationship between obesity, microvascular 
function, and hydration status in individuals with higher levels of adiposity (i.e., morbid obesity).  
Conclusions 
We hypothesized that OB individuals would have impaired cutaneous vasodilatory and 
sweating responses when euhydrated in response to intradermal infusion of MCh and SNP versus 
N-OB counterparts. Moreover, we hypothesized that hypohydration exacerbate these 
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impairments to a greater extent in OB versus N-OB. No differences were present between groups 
or hydration condition in MCh-mediated CVC, suggesting body type and hydration status did not 
influence endothelium-dependent cutaneous vasodilation. In contrast, OB individuals required a 
significantly higher dose of SNP to elicit 50% of the maximal CVC response versus N-OB, 
suggesting impaired endothelium-independent vasodilation. Interestingly, hypohydration tended 
to attenuate endothelium-independent CVC in N-OB but not OB individuals versus a euhydrated 
condition. This provides direct evidence for the added influence of whole-body hypohydration 
on endothelium-independent cutaneous vasodilation. Future studies should continue to examine 
the effect of hypohydration on microvascular function in healthy and other clinical populations 
with known microvascular dysfunction (i.e., individuals with type II diabetes and/or 
hypertension).  
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Figure Captions 
Figure 1. Cutaneous vascular conductance (CVC, expressed as a percentage of maximum) in 
non-obese (N-OB) and obese (OB) subjects at baseline (Base) and in response to incremental 
sub-cutaneous infusion of methacholine chloride (MCh) while euhydrated. 
 
Figure 2A. Cutaneous vascular conductance (CVC, expressed as a percentage of maximum) in 
non-obese subjects at baseline (Base) and in response to incremental sub-cutaneous infusion of 
methacholine chloride (MCh) while euhydrated (EU) and hypohydrated (HY). 
 
Figure 2B. Cutaneous vascular conductance (CVC, expressed as a percentage of maximum) in 
obese subjects at baseline (Base) in response to incremental sub-cutaneous infusion of 
methacholine chloride (MCh) while euhydrated (EU) and hypohydrated (HY). 
 
Figure 3. Cutaneous vascular conductance (CVC, expressed as a percentage of maximum) in 
non-obese (N-OB) and obese (OB) subjects at baseline (Base) in response to incremental sub-
cutaneous infusion of sodium nitroprusside (SNP) while euhydrated. 
 
Figure 4A. Cutaneous vascular conductance (CVC, expressed as a percentage of maximum) in 
non-obese subjects at baseline (Base) and in response to incremental sub-cutaneous infusion of 
sodium nitroprusside (SNP) while euhydrated (EU) and hypohydrated (HY). 
 
Figure 4B. Cutaneous vascular conductance (CVC, expressed as a percentage of maximum) in 
obese subjects at baseline (Base) and in response to incremental sub-cutaneous infusion of 
sodium nitroprusside (SNP) while euhydrated (EU) and hypohydrated (HY). 
 
Figure 5. Local sweat rate (LSR) in non-obese (N-OB) and obese (OB) subjects at baseline 
(Base) and in response to incremental sub-cutaneous infusion of methacholine chloride while 
euhydrated. 
 
Figure 6A. Local sweat rate (LSR) in non-obese subjects at baseline (Base) and in response to 
incremental sub-cutaneous infusion of methacholine chloride while euhydrated (EU) and 
hypohydrated (HY). 
 
Figure 6B. Local sweat rate (LSR) in obese subjects at baseline (Base) and in response to 
incremental sub-cutaneous infusion of methacholine chloride while euhydrated (EU) and 
hypohydrated (HY). 
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Figure 3.  
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Figure 4. 
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CHAPTER FOUR 
 
Conclusions 
 These studies sought to determine if impairments in thermoregulatory responses were 
present in obese males via both centrally- and peripherally-mediated mechanisms compared to 
non-obese. In order to investigate this, we compared thermoregulatory responses in non-obese 
and obese males during exercise heat-stress (i.e., centrally-mediated) and in response to 
intradermal infusion of vasoactive substances (i.e., peripherally-mediated). Further, we compared 
these groups while subjects were euhydrated and hypohydrated in order to examine potential 
differences between groups in the physiological modification of thermoregulation attributed to 
hypohydration. During exercise-heat stress, cutaneous vasodilation and sweating responses were 
similar between groups when euhydrated. However, obese subjects had a greater increase in 
rectal temperature versus non-obese. Hypohydration affected cutaneous vasodilatory and 
sweating responses in a similar magnitude in both groups but compared to the euhydrated 
condition, hypohydration increased the end-exercise rectal temperature in non-obese but not 
obese subjects. This suggests that, despite a similar ability of obese subjects to increase 
cutaneous vasodilation and sweating compared to non-obese when euhydrated, obese were 
unable to prevent rectal temperature from increasing to levels observed when hypohydrated.  
During intradermal drug infusion, both non-obese and obese males exhibited similar 
endothelium-dependent vasodilation and sweating responses when either euhydrated or 
hypohydrated. However, obese showed attenuated cutaneous vasodilation in response to the 
nitric oxide donor sodium nitroprusside (SNP) versus non-obese when euhydrated, suggesting 
 83 
 
impaired endothelium-independent vasodilation. Hypohydration did not affect endothelium-
dependent, -independent, or sweating responses differently between groups.  
These data suggest that during exercise-heat stress, obese males are not able to 
appropriately increase cutaneous vasodilation and sweating in response to an elevated rectal 
temperature versus non-obese when euhydrated. Moreover, hypohydration appears to affect non-
obese to a greater extent versus obese, with non-obese subjects exhibiting a significantly higher 
rectal temperature when hypohydrated versus euhydrated, but no difference between hydration 
conditions in obese. In addition, obese males exhibit impaired peripherally-mediated cutaneous 
vasodilation in response to intradermal infusion of an endothelium-independent vasodilator, 
independent of hydration status. The exact mechanism(s) for this peripheral impairment are not 
clear, but may be related to microvascular dysfunction associated with obesity. Future studies 
should seek to examine the relationship between thermoregulatory responses and hydration 
status in other populations that may have impaired centrally- and/or peripherally-mediated 
vasodilatory and sweating responses (i.e., females, older individuals, individuals with Type II 
diabetes mellitus).   
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st
 (
T
H
):
 i
n
 t
h
e 
E
U
 t
ri
al
s,
 t
h
er
e 
w
as
 a
 m
ai
n
 e
ff
ec
t 
o
f 
ti
m
e 
(p
 =
 0
.0
0
4
) 
b
u
t 
n
o
 i
n
te
ra
ct
io
n
 b
et
w
ee
n
 g
ro
u
p
 a
n
d
 t
im
e 
(p
 =
 
0
.5
1
8
).
 H
y
p
o
h
y
d
ra
ti
o
n
 d
id
 n
o
t 
af
fe
ct
 g
ro
u
p
s 
d
if
fe
re
n
tl
y
, 
w
it
h
 b
o
th
 g
ro
u
p
s 
sh
o
w
in
g
 i
n
cr
ea
se
d
 T
H
 o
v
er
 t
im
e 
(p
 =
 0
.0
0
3
) 
w
it
h
 n
o
 
in
te
ra
ct
io
n
 (
p
 =
 0
.5
9
6
).
 
 
T
h
er
m
a
l 
se
n
sa
ti
o
n
 (
T
S
):
 i
n
 t
h
e 
E
U
 t
ri
al
s,
 T
S
 i
n
cr
ea
se
d
 o
v
er
 t
im
e 
(p
 <
 0
.0
0
1
) 
b
u
t 
th
er
e 
w
as
 n
o
 i
n
te
ra
ct
io
n
 b
et
w
ee
n
 g
ro
u
p
 a
n
d
 
ti
m
e 
(p
 =
 0
.1
4
2
).
 H
y
p
o
h
y
d
ra
ti
o
n
 d
id
 n
o
t 
af
fe
ct
 g
ro
u
p
s 
d
if
fe
re
n
tl
y
, 
w
it
h
 b
o
th
 g
ro
u
p
s 
sh
o
w
in
g
 i
n
cr
ea
se
d
 T
S
 o
v
er
 t
im
e 
(p
 =
 0
.0
2
2
) 
w
it
h
 
n
o
 i
n
te
ra
ct
io
n
 (
p
 =
 0
.2
8
8
).
 
 
M
u
sc
le
 p
a
in
 (
M
P
):
 i
n
 t
h
e 
E
U
 t
ri
al
s,
 M
P
 i
n
cr
ea
se
d
 o
v
er
 t
im
e 
(p
 <
 0
.0
0
1
) 
an
d
 t
h
er
e 
w
as
 a
 s
ig
n
if
ic
an
t 
in
te
ra
ct
io
n
 b
et
w
ee
n
 g
ro
u
p
 
an
d
 t
im
e 
(p
 =
 0
.0
0
4
).
 O
B
 r
ep
o
rt
ed
 h
ig
h
er
 v
al
u
es
 o
f 
M
P
 a
t 
1
5
, 
3
0
, 
4
5
, 
an
d
 6
0
 m
in
 v
er
su
s 
N
-O
B
 (
al
l 
p
 <
 0
.0
5
).
 H
y
p
o
h
y
d
ra
ti
o
n
 d
id
 n
o
t 
af
fe
ct
 t
h
e 
ch
an
g
e 
o
v
er
 t
im
e 
v
er
su
s 
E
U
 (
p
 =
 0
.1
7
7
),
 n
o
r 
w
as
 t
h
er
e 
a 
si
g
n
if
ic
an
t 
in
te
ra
ct
io
n
 b
et
w
ee
n
 t
im
e 
an
d
 g
ro
u
p
 (
p
 =
 0
.1
3
7
).
  
 
 
M
o
ti
va
ti
o
n
 t
o
 c
o
n
ti
n
u
e 
(M
O
T
):
 i
n
 t
h
e 
E
U
 t
ri
al
s,
 M
O
T
 i
n
cr
ea
se
d
 o
v
er
 t
im
e 
(p
 =
 0
.0
4
7
) 
an
d
 t
h
er
e 
w
as
 a
 s
ig
n
if
ic
an
t 
in
te
ra
ct
io
n
 
b
et
w
ee
n
 g
ro
u
p
 a
n
d
 t
im
e 
(p
 =
 0
.0
4
3
).
 N
-O
B
 r
ep
o
rt
ed
 l
o
w
er
 v
al
u
es
 o
f 
M
O
T
 a
t 
4
5
 a
n
d
 6
0
 m
in
 v
er
su
s 
O
B
 w
h
en
 H
Y
 (
b
o
th
 p
 <
 0
.0
1
).
 
H
y
p
o
h
y
d
ra
ti
o
n
 d
id
 n
o
t 
af
fe
ct
 t
h
e 
ch
an
g
e 
o
v
er
 t
im
e 
v
er
su
s 
E
U
 (
p
 =
 0
.9
1
0
),
 n
o
r 
w
as
 t
h
er
e 
a 
si
g
n
if
ic
an
t 
in
te
ra
ct
io
n
 b
et
w
ee
n
 t
im
e 
an
d
 
g
ro
u
p
 (
p
 =
 0
.2
0
5
).
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C
o
m
fo
rt
 (
C
O
M
):
 i
n
 t
h
e 
E
U
 t
ri
al
s,
 C
O
M
 i
n
cr
ea
se
d
 (
N
o
te
: 
h
ig
h
er
 C
O
M
 i
n
d
ic
at
es
 g
re
at
er
 d
is
co
m
fo
rt
) 
o
v
er
 t
im
e 
(p
 <
 0
.0
0
1
) 
an
d
 
th
er
e 
w
as
 a
 s
ig
n
if
ic
an
t 
in
te
ra
ct
io
n
 b
et
w
ee
n
 g
ro
u
p
 a
n
d
 t
im
e 
(p
 =
 0
.0
4
1
).
 H
y
p
o
h
y
d
ra
ti
o
n
 d
id
 n
o
t 
af
fe
ct
 g
ro
u
p
s 
d
if
fe
re
n
tl
y
, 
w
it
h
 b
o
th
 
g
ro
u
p
s 
sh
o
w
in
g
 n
o
 c
h
an
g
e 
o
v
er
 t
im
e 
(p
 =
 0
.7
2
8
) 
v
er
su
s 
E
U
 a
n
d
 n
o
 i
n
te
ra
ct
io
n
 b
et
w
ee
n
 g
ro
u
p
 a
n
d
 t
im
e 
(p
 =
 0
.4
5
9
).
 
 
R
a
ti
n
g
 o
f 
p
er
ce
iv
ed
 e
xe
rt
io
n
 (
R
P
E
):
 i
n
 t
h
e 
E
U
 t
ri
al
s,
 R
P
E
 i
n
cr
ea
se
d
 o
v
er
 t
im
e 
(p
 <
 0
.0
0
1
) 
an
d
 t
h
er
e 
w
as
 a
 s
ig
n
if
ic
an
t 
in
te
ra
ct
io
n
 b
et
w
ee
n
 g
ro
u
p
 a
n
d
 t
im
e 
(p
 =
 0
.0
0
4
).
 R
P
E
 w
as
 s
ig
n
if
ic
an
tl
y
 h
ig
h
er
 i
n
 O
B
 v
er
su
s 
N
-O
B
 a
t 
3
0
 a
n
d
 4
5
 m
in
 (
b
o
th
 p
 <
 0
.0
5
).
 
H
y
p
o
h
y
d
ra
ti
o
n
 d
id
 n
o
t 
af
fe
ct
 g
ro
u
p
s 
d
if
fe
re
n
tl
y
, 
w
it
h
 b
o
th
 g
ro
u
p
s 
sh
o
w
in
g
 n
o
 c
h
an
g
e 
o
v
er
 t
im
e 
(p
 =
 0
.5
9
3
) 
v
er
su
s 
E
U
 a
n
d
 n
o
 
in
te
ra
ct
io
n
 b
et
w
ee
n
 g
ro
u
p
 a
n
d
 t
im
e 
(p
 =
 0
.9
5
7
).
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Appendix B 
 
Figure Captions 
 
Figure 1. Changes in rectal temperature (Trec; A), mean skin temperature (Tsk; B) and mean body 
temperature (Tb; C) in non-obese (N-OB) and obese (OB) subjects while hypohydrated. 
*significant difference between groups (p < 0.05).  
 
Figure 2. Changes in cutaneous vascular conductance (CVC; A) and local sweat rate (LSR; B) in 
non-obese (N-OB) and obese (OB) subjects while hypohydrated. *significant difference between 
groups (p < 0.05).  
 
Figure 3. Changes in sweat gland activation (SGA; A) and sweat gland output (SGO; B) in non-
obese (N-OB) and obese (OB) subjects while hypohydrated. *significant difference between 
groups (p < 0.05).  
 
Figure 4. Changes in heart rate (HR; A) and mean arterial pressure (MAP; B) in non-obese (N-
OB) and obese (OB) subjects while hypohydrated. . No significant differences between groups at 
any time point (all p > 0.05).  
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Appendix C 
